Aldrich syndrome

Aldrich Syndrome

Aldrich Syndrome, more commonly known as Wiskott-Aldrich Syndrome (WAS), is a rare X-linked recessive immunodeficiency disorder characterized by a triad of symptoms: eczema, thrombocytopenia (low platelet count), and recurrent infections due to immunodeficiency. This condition primarily affects males, as it is linked to mutations in the WAS gene located on the X chromosome.

Clinical Features

The clinical presentation of Aldrich Syndrome is variable, but the hallmark features include:

• Eczema: Patients often present with atopic dermatitis, which can be severe and difficult to manage.
• Thrombocytopenia: This is often the first sign of the disease, with patients exhibiting petechiae, bruising, and an increased risk of bleeding due to low platelet counts.
• Recurrent Infections: Due to the immunodeficiency, patients are susceptible to bacterial, viral, and fungal infections. Common infections include otitis media, pneumonia, and sepsis.

Pathophysiology

Aldrich Syndrome is caused by mutations in the WAS gene, which encodes the Wiskott-Aldrich Syndrome protein (WASP). WASP is crucial for the function of hematopoietic cells, including T cells, B cells, and platelets. Mutations in the WAS gene lead to defective actin cytoskeleton reorganization, affecting cell signaling, migration, and immune synapse formation.

Diagnosis

Diagnosis of Aldrich Syndrome is based on clinical findings, family history, and laboratory tests. Key diagnostic tests include:

• Complete Blood Count (CBC): Reveals thrombocytopenia and small platelets.
• Immunological Tests: Show abnormalities in T and B cell function.
• Genetic Testing: Confirms mutations in the WAS gene.

Treatment

Management of Aldrich Syndrome involves supportive care and definitive treatment:

• Supportive Care: Includes platelet transfusions, antibiotics for infections, and topical treatments for eczema.
• Immunoglobulin Replacement Therapy: Helps prevent infections.
• Hematopoietic Stem Cell Transplantation (HSCT): The only curative treatment, which can restore normal immune function.

Prognosis

The prognosis for patients with Aldrich Syndrome has improved with advances in treatment, particularly with the use of HSCT. Early diagnosis and intervention are crucial for improving outcomes.

Also see

• X-linked recessive inheritance
• Immunodeficiency disorders
• Eczema
• Thrombocytopenia